baber/WOPTO huggingface dataset:
Patent NZ-506361-A (NZ)
Title: Two surface pivotable table top
Inventor: DRAKE KENNETH CHARLES
IPC: A63D15/04
Filed: 2000-08-16
Abstract: A pivoting table (1) comprising a pivoting portion of the table (4), where the uppermost table surface (10) may be pivoted through at least 180° to reveal the lowermost game-playing surface (11). The structural support for the pivoting portion of the table (4) is formed of two lateral frame members (5,6) at each end (2,3) of the table (1), and a centrally located, tubular frame member (7) running between the lateral frame members (5,6). The frame members are joined to form an I-shaped frame for the table. The pivoting portion of the table (4) is centrally engaged about the longitudinal frame member (7) and within the I-shaped frame. Bushes (12a, 12b, 12c, 12d) mounted in the pivoting portion of the table (4) provide bearing support during rotation between operating positions.
Patent NZ-506413-A (NZ)
Title: Retracting needle syringe with re-use prevention features
Inventor: CAIZZA RICHARD
IPC: A61M5/32
Filed: 1999-12-02
Abstract: A retracting needle syringe is described which allows safe and easy disposal of a syringe and prevents re-use of the syringe by destroying the plunger rod and needle hub and retracting the needle into the plunger rod. Once the safety feature is activated, positive or negative pressure in the barrel to draw out medication is defeated. The retracting needle safety feature requires only an increase of force along the same line of action as the injection stroke. This allows for safe, one-handed injection, which is critical in some situations. The retracting needle syringe of the present invention also minimizes the amount of wasted medication because the plunger rod incorporates a plunger tip that occupies the entire volume inside the barrel. Because the retracting needle syringe uses standard luer-lock fittings, it can be used with a variety of standard needles that do not have retracting cannula. This gives the healthcare professional or patient the ability to use a large gauge needle to fill the syringe from a vial or other container before attaching the safety needle for injection. Lastly, the plunger can be completely encapsulated by the barrel upon activation of the retracting needle syringe safety feature which will prevent re-use of the syringe and allow for safe and easy disposal.
Patent NZ-506941-A (NZ)
Title: Self-regulated apoptosis of inflammatory cells by gene therapy
Inventor: TATAKE REVATI J
IPC: A61K48/00
Filed: 1999-01-12
Abstract: A chimeric nucleic acid molecule comprising at least one TNFAlpha promoter enhancer region attached to a TNFAlpha promoter, the enhancer region comprising the nucleic acid SEQ ID NO: 4, 5, 11, 12 as set out in the specification or conservative substitution or allelic variants thereof; and the TNFAlpha promoter further being attached to an apoptosis-inducing nucleic acid sequence encoding the inactivating di-peptide deleted Granzyme B protein or conservative substitution or allelic variant thereof which in turn is further attached to a 3'UTR nucleic acid sequence.
Patent NZ-512217-A (NZ)
Title: Method of screening candidate compounds for susceptibility to selected enzyme, e.g. cytochrome P450 (CYP) or xanthine oxidase
Inventor: THAKKER DHIREN R
IPC: G01N33/15
Filed: 1999-11-15
Abstract: A method of screening a candidate compound for susceptibility to metabolism by a selected enzyme.  The method includes the steps of reacting the candidate compound, an indicator compound precursor and the selected enzyme, the enzyme characterized as having a side reaction associated with metabolic activity of the enzyme wherein a chemical species capable of reacting with the indicator compound precursor is produced; and detecting an indicator compound, the indicator compound produced from the indicator compound precursor by reaction with the chemical species produced from the side reaction associated with metabolic activity of the enzyme, the detection of the indicator compound indicating the susceptibility of the candidate compound to metabolism by the enzyme. A preferred example of the selected enzyme is a cytochrome P450 (CYP).  Other enzymes include xanthine oxidase and some CYP isozymes namely; CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4 or combinations thereof.
Patent NZ-512287-A (NZ)
Title: Pharmaceutical compositions comprising a lipophilic drug in a propylene glycol ester of a higher fatty acid carrier, where 60% of the ester is a monoester
Inventor: MULYE NIRMAL
IPC: A61K9/107
Filed: 1999-12-10
Abstract: Described is a pharmaceutical composition comprising a pharmaceutically effective amount of a lipophilic drug in association with a pharmaceutical carrier.  The carrier comprises a lipophilic drug solubilizing effective amount of a propylene glycol monoester of a C6-C18 fatty acid having at least 60 % by weight monoester based on the total weight of the propylene glycol ester and a non-ionic surfactant.
Patent NZ-512713-A (NZ)
Title: New use of melagatran
Inventor: KIRK IAN
IPC: A61K38/05
Filed: 2000-01-13
Abstract: Disclosed is the use of melagatran , or a pharmaceutically acceptable derivative or prodrug thereof, in the manufacture of a medicament for the treatment of inflammation , particularly in patients with disease in which inhibition of thrombin is desirable and wherein the inflammation may cause coagulation or clotting . Treatment of such patients reduces the risk of the inflammation causing formation of a thrombus . Also disclosed are combinations of meglatran and other anti-inflammatory compounds .
Patent NZ-513302-A (NZ)
Title: Article of manufacture having illusion of dimpled golf ball surface and method of creating the same
Inventor: JOHNSTON NIK L
IPC: D06P5/00
Filed: 2000-01-28
Abstract: An article of manufacture comprising a substrate material (20) and a pattern of images (32) disposed on it. The pattern formed by a plurality of similar images are organised in a matrix.
Patent NZ-514133-A (NZ)
Title: N-acyl phosphatidylethanolamine-mediated liposomal drug delivery
Inventor: MEERS PAUL R
IPC: A61K9/127
Filed: 1997-10-15
Abstract: This invention provides liposomes containing one or more N-acylated phosphatidylethanolamines, such liposomes being useful for localizing the delivery of bioactive agents to cells.
Patent NZ-522842-A (NZ)
Title: Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
Inventor: ASHVAR CLAUDINE S
IPC: A61P31/12
Filed: 2001-06-06
Abstract: Disclosed is a liposome comprising at least one phosphatidylcholine, a cholesterol, and (S)-2-(5-(((1,2-Dihydro-3-methyl-1-oxobenzo[f]quinazoline-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid. Also disclosed is a liposome comprising (S)-2-(5-(((1,2-Dihydro-3-methyl-1-oxobenzo[f]quinazoline-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid, encapsulated in a liposome, wherein the liposome is comprised of hydrogenated soy phosphatidylcholine (HSPC) and cholesterol and wherein HSPC:cholesterol is in a molar ratio of about 2:1, and wherein the HSPC to (S)-2-(5-(((1,2-Dihydro-3-methyl-1-oxobenzo[f]quinazoline-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid molar ratio is from 8:1 to 20:1, and the liposome is unilamellar having a size of less than 100 nm. The liposome is used in the manufacture of medicaments for inhibiting the growth of a tumour.
Patent NZ-522916-A (NZ)
Title: Therapeutic combinations of fatty acids
Inventor: HORROBIN DAVID FREDERICK
IPC: A61P31/04
Filed: 2001-06-20
Abstract: Eicosapentaenoic acid or any appropriate derivative (EPA) is disclosed in combination with arachidonic acid (AA) or an AA precursor, selected from DGLA and GLA, to give a pharmaceutical formulation is disclosed. Such formulations are useful in the treatment or prevention of psychiatric, neurological or other central or peripheral nervous system diseases, such as depression, bipolar disorder, Alzheimer's disease, other dementia or Parkinson's disease, or a disease selected from asthma or other respiratory disease; a disease of the gastrointestinal tract; an inflammatory disease; a cardiovascular disease; a dyslipidaemia, diabetes or other form of metabolic disease; a dermatological disease; a kidney or urinary tract disease; a liver disease; a disease of the male or female reproductive system or related secondary sexual organs; a cancer; a disease of the head or neck; and an infection caused by a virus, bacterium, fungus, protozoa or other organism
Patent NZ-526306-A (NZ)
Title: Process of preparing a fluid rare earth alkoxylation catalyst
Inventor: EDWARDS CHARLES LEE
IPC: B01J27/18
Filed: 2001-12-13
Abstract: Process for the preparation of a fluid rare earth phosphate catalyst composition is disclosed wherein the process comprises the steps: a) providing a rare earth salt soluble in active hydrogen containing organic compound at a temperature of less than 120 °C; b) adding and dissolving the rare earth salt in the active hydrogen containing organic compound thereby producing a rare earth/organic solution; and c) adding phosphoric acid to the rare earth/organic solution in a rare earth salt to phosphoric acid molar ratio in the range of 0.7:1 to 1.3:1 thereby producing the fluid rare earth phosphate catalyst composition. Also disclosed is a process for the preparation of alkylene oxide adducts of active hydrogen containing organic compounds, which comprises contacting an alkylene oxide reactant comprising one or more vicinal alkylene with an active hydrogen containing reactant comprising one or more active hydrogen containing organic compounds, in the presence of a catalytically effective amount of such a fluid catalyst composition.
Patent NZ-526515-A (NZ)
Title: Fiber optic component cleaning device
Inventor: FORREST EDWARD J
IPC: B08B1/00
Filed: 2003-06-17
Abstract: A fiber optic component-cleaning device is disclosed. This device comprises a container having an opening, a soft work surface on a face formed in a side thereof and a plurality of cleaning wipes located inside the container. The cleaning wipes are fed from the inside of the container through the opening and placed on the work surface for cleaning. A method of cleaning a fiber optic component is also described and comprises the following steps: - Feeding a cleaning wipe through an opening in a container - Placing the wipe on a soft work surface on a face of the container for cleaning - Drawing the fiber optic component over the wipe The device is shown below and the components are described within the specification.
Patent NZ-530077-A (NZ)
Title: Extruder for making a board based on a binder such as gypsum plaster
Inventor: DERUSCO CHRISTIAN
IPC: B28B19/00
Filed: 2002-06-06
Abstract: The invention concerns a method for making a board based on a binder such as gypsum plaster, cement or the like; it comprises steps which consist in: a) mixing a composition designed to form the board body with water; b) depositing the mixture on a moving support, which is continuously driven by a belt conveyor, said mixture passing through an extruder forming a board, said extruder being subjected to vibrations; c) cutting the resulting board at least lengthwise. The invention also concerns an extruder for implementing said method of the type comprising a transverse extruding die (40) provided with an upper lip and a lower lip (38) which bears on its lower surface at least a vibrator (42). The invention further concerns a board based on a binder such as gypsum plaster, cement or the like, produced by said method and the use of such a board, wherein the binder is cementitious, to form or cover walls, partitions, floors or roofs, inside or outside buildings, such as industrial kitchens, agri-food laboratories, showers, bathrooms, ponds or pools, and/or halls frequently washed with water jet, such as halls of agricultural buildings or of industrial slaughterhouses. Finally the invention concerns the use of such a board, wherein the binder is based on gypsum plaster, to form or cover walls, partitions or the like.
Patent NZ-530572-A (NZ)
Title: Combinations comprising bisphosphonate and epothilones, and pharmaceutical uses thereof
Inventor: CHEN TIANLING
IPC: A61K33/243
Filed: 2002-07-18
Abstract: Disclosed herein is a combination which comprises (a) a bisphosphonate selected from etridonic acid, clodronic acid, tiludronic acid, pamidronic acid, alendronic acid, ibandronic acid, risedronic acid and zoledronic acid, and (b) an epothilone derivative of formula (I), wherein A represents O or NRN, wherein RN is hydrogen or lower alkyl, R is hydrogen or lower alkyl, and Z is O or a bond, in which the active ingredients (a) and (b) are present in each case in free form or in the form of a pharmaceutically acceptable salt and optionally at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular for the delay of progression or treatment of a proliferative disease, especially a solid tumor disease; a pharmaceutical composition, a commercial package or product comprising such a combination; the use of such a combination for the preparation of a medicament for the delay of progression or treatment of a proliferative disease.
Patent NZ-533833-A (NZ)
Title: Targeted retrograde gene delivery to motor neurons
Inventor: KASPAR BRIAN K
IPC: C12N5/06
Filed: 2002-12-20
Abstract: Use of an adeno-associated viral (AAV) vector together with a heterologous gene in the manufacture of a medicament for the treatment of amyotrophic lateral sclerosis (ALS) and methods of use of the medicament by contacting either the synaptic portion of a neuron, for example or a muscle tissue innervated by the neuron, with a viral vector comprising a heterologous gene, wherein the viral vector enters said neuron and is retrogradely moved to the cell body. Additionally, methods for expressing secreted proteins from a nerve cell body as well as methods for treating neurodegenerative disorders are described.
Patent NZ-543960-A (NZ)
Title: CD20-specific antibodies and methods of employing same
Inventor: TEDDER THOMAS F
IPC: C07K16/28
Filed: 2004-05-07
Abstract: Disclosed is a monoclonal antibody that specifically binds to CD20 wherein the antibody has a treatment effective dosage range of 125mg/m2 or less which results in at least a 75% depletion in circulating B cells, tissue B cells or both in a subject.
Patent NZ-544064-A (NZ)
Title: Electronic security system for monitoring and recording activity and data relating to persons
Inventor: SAJKOWSKY JAMES M
IPC: G07C9/00
Filed: 2004-06-17
Abstract: An apparatus is disclosed for providing secure and unique identification of persons, comprising a device for receiving electromagnetic data signals and storing the signals. The data signal includes identifier data fields, and a travel data field. The identifier fields can comprise a biometric field, and an alphanumeric field for individual's address and name. The travel identifier field can comprise passport data, and data relating to entry or exit from a country. A system is also disclosed comprising the identification apparatus, and a writer and controller and reader for interrogating the identification apparatus. The identification apparatus can be an RFID tag operating at 915 MHz.
Patent NZ-545124-A (NZ)
Title: Modular panelling system
Inventor: GATTELARI JOE
Filed: 2006-02-03
Abstract: A system for the installation of wall panelling and shelving includes panelling consisting of at least one upper panel member 1 and at least one lower panel member 2, and shelving supported by a support member. The support member features a vertical support plate, which is adapted to hang from the upper edge of said lower panel member 2, and one or more cantilever support projections 9, which are adapted to support shelves, drawer- boxes or the like, and which extend outward from the support plate. In a fully installed state, the support member is secured in position by way of being sandwiched between a lower surface of said upper panel member 1 and the upper surface of said lower panel member 2. The support member extends substantially long the entire width of, and forms the connection between, said upper and lower panel members 1,2.
Patent NZ-545837-A (NZ)
Title: Imidazopyridine substituted tropane derivatives with CCR5 receptor antagonist activity for the treatment of HIV and inflammation
Inventor: STUPPLE PAUL ANTHONY
IPC: C07D519/00
Filed: 2004-09-28
Abstract: Disclosed are 2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine derivatives of formula (I), or a pharmaceutically acceptable salt, solvate, complex, prodrug or isotopically labelled compound thereof wherein: R1 is alkyl; and R2 is alkyl or cycloalkyl, wherein said alkyl is optionally substituted by CF3. Also disclosed is a pharmaceutical composition which includes a compound as defined above together with one or more pharmaceutically acceptable excipients, diluents or carriers, and which may further include one or more additional therapeutic agents. The use of a compound as defined above for the manufacture of a medicament for the treatment of a disorder in which the modulation of CCR5 receptors is implicated (disorders such as HIV, a reteroviral infection genetically related to HIV, AIDS, or inflammatory diseases) is further disclosed.
Patent NZ-547095-A (NZ)
Title: Amide derivatives
Inventor: BROWN DEARG SUTHERLAND
IPC: C07D401/04
Filed: 2004-10-22
Abstract: Disclosed are benzamide derivatives of formula (I) and pharmaceutically-acceptable salts thereof; wherein m is 0-2 and each R1 is a group such as hydroxy, halogeno, trifluoromethyl heterocyclyl and heterocyclyloxy; R2 is halogeno, trifluoromethyl or (1-6C)alkyl; R3 is hydrogen, halogeno or (1-6C)alkyl; and R4 is (3-6C)cycloalkyl; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.
Patent NZ-551980-A (NZ)
Title: A method of providing treatment for an auditory system disorder
Inventor: DAVIS PAUL BENJAMIN
IPC: A61B5/12
Filed: 2000-03-17
Abstract: A device for providing a stimulus to the auditory system of an individual experiencing tinnitus or hyperacusis is disclosed. The device comprises a storage device for storing an audio signal including peaks and troughs, wherein the audio signal is a two-channel stereo audio signal; a signal filter configured to spectrally modify at least a portion of each channel of the audio signal independently in accordance with a predetermined masking algorithm designed to modify at least one of the peaks and the troughs of at least a portion of each channel of the audio signal at independently selected frequencies, and an output for outputting the spectrally modified audio signal. The predetermined masking algorithm accounts for the basic audiometric configuration of the individual whereby, in use at a comfortable listening level, when the spectrally modified audio signal is heard by the individual during the peaks, the tinnitus is substantially completely obscured and the individual perceives significant masking of the tinnitus, and during troughs, the individual may occasionally perceive the tinnitus.
Patent NZ-560717-A (NZ)
Title: Networking hardware element to couple computer network elements and method of displaying a network layout map thereon
Inventor: PHAM ANTHONY
IPC: H04W24/00
Filed: 2007-08-17
Abstract: A networking hardware element to couple computer network elements comprises one or more transceivers configured to receive communication signals from one or more of the computer network elements and to forward the communication signals to one or more different ones of the computer network elements; a network diagnostic mechanism capable of: iteratively scanning the transceivers to monitor the computer network elements; mapping the computer network elements; and determining a connection status for the computer network elements coupled to the networking hardware element based on monitoring the transceivers; and a display at a surface of the networking hardware element and capable of: communicating with the network diagnostic mechanism; and displaying a network layout map of: representations of the computer network elements; and the connection status of the computer network elements.
Patent NZ-561791-A (NZ)
Title: Improvements relating to graphical user interfaces
Inventor: STEIN MICHAEL LEWIS
IPC: G06F9/44
Filed: 2004-03-24
Abstract: A method is provided which constructs a graphical user interface, the method comprises the steps of a)collating content regarding a particular workflow, b) recording that content in a database as a series of steps of a hierarchically structured clinical diagnosis workflow commencing with a symptom in relation to one of a plurality of medical conditions, the workflow steps providing a methodology to determine which of the medical conditions is responsible for generating this symptom; and generating a graphical representation of the hierarchical workflow structure, which can be used to guide a user through the workflow. The graphical representation includes a plurality of interlinked nodes where each node corresponds to a specific point within the hierarchical workflow structure.
Patent NZ-562183-A (NZ)
Title: Systems, methods, and apparatus for highband excitation generation
Inventor: VOS KOEN BERNARD
IPC: G10L25/90
Filed: 2006-04-03
Abstract: A method of generating a highband excitation signal is disclosed. The method includes: harmonically extending the spectrum of a signal that is based on a lowband excitation signal; calculating a time-domain envelope of a signal that is based on the lowband excitation signal; generating a noise signal according to a deterministic function of information within an encoded speech signal; modulating the noise signal according to the time-domain envelope; and combining a harmonically extended signal based on a result of the harmonically extending and a modulated noise signal based on a result of the modulating. The highband excitation signal is based on a result of the combining.
Patent NZ-562241-A (NZ)
Title: Varying energy outputs along lengths of temperature limited heaters with a selected Curie temperature to provide reduced heat
Inventor: GINESTRA JEAN CHARLES
IPC: E21B36/04
Filed: 2006-04-21
Abstract: Disclosed is a system for heating a subsurface formation. The system comprises an elongated heater in an opening in the formation, the elongated heater having an upper and a lower portion along the length of the heater that have different energy outputs. The upper and lower portion of the elongated heater each comprising a temperature limited portion with a selected Curie temperature at which the portion provides a reduced heat output. The portions of the heater being configured to provide heat to the formation with the different energy outputs so that the heater heats different portions of the formation at different selected heating rates. The Curie temperature in the upper portion of the temperature limited heater is lower than in the lower portion of the heater.
Patent NZ-562521-A (NZ)
Title: Roofing hip or ridge tile with nailable cementitious portions hinged together
Inventor: KUIZENGA MARCUS
IPC: C04B28/02
Filed: 2004-06-21
Abstract: A cementitious roofing article is disclosed for covering hip or ridge areas of a roof, having nailable portions connected hingedly so as the portions are pivotable relative to each other about a central axis.